IDYA — Ideaya Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $2.56bn
- $1.89bn
- $7.00m
- 43
- 12
- 68
- 35
Annual cashflow statement for Ideaya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.5 | -49.8 | -58.7 | -113 | -274 |
| Depreciation | |||||
| Non-Cash Items | 4.17 | 10.1 | 12.3 | 8.47 | 13 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 84.4 | -17.8 | -43 | -13.2 | 11.5 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 55.5 | -55.8 | -87.2 | -115 | -248 |
| Capital Expenditures | -0.493 | -2.64 | -3.44 | -2.37 | -3.86 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -146 | -67 | -30 | -156 | -499 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -146 | -69.7 | -33.4 | -158 | -503 |
| Financing Cash Flow Items | 20 | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 129 | 145 | 97.2 | 363 | 678 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 38 | 20 | -23.4 | 89 | -72.6 |